GRANULES - Granules India Ltd. Share Price

Pharmaceuticals & Biotechnology

Sharesguru Stock Score

GRANULES

58/100

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 4 years

₹873.85+35.20(+4.20%)

Market Closed as of Aug 7, 2026, 15:30 IST

Select time range

Pros

Profitability: Recent profitability of 12% is a good sign.

Size: Market Cap wise it is among the top 20% companies of india.

Balance Sheet: Strong Balance Sheet.

Past Returns: Outperforming stock! In past three years, the stock has provided 39.3% return compared to 7.9% by NIFTY 50.

Smart Money: Smart money is taking extra interest in the stock as they increase their holdings.

Valuation
Market Cap	21.65 kCr
Price/Earnings (Trailing)	32.29
Price/Sales (Trailing)	3.84
EV/EBITDA	17.02
Price/Free Cashflow	92.13
MarketCap/EBT	24.58
Enterprise Value	22.11 kCr

Fundamentals
Revenue (TTM)	5.64 kCr
Rev. Growth (Yr)	20.6%
Earnings (TTM)	662.35 Cr
Earnings Growth (Yr)	59.8%

Profitability
Operating Margin	15%
EBT Margin	16%
Return on Equity	13.03%
Return on Assets	8.58%
Free Cashflow Yield	1.09%

Growth & Returns
Price Change 1W	6%
Price Change 1M	1.7%
Price Change 6M	55%
Price Change 1Y	94.2%
3Y Cumulative Return	39.3%
5Y Cumulative Return	18.2%
7Y Cumulative Return	37%
10Y Cumulative Return	20%

Cash Flow & Liquidity
Cash Flow from Investing (TTM)	-773.21 Cr
Cash Flow from Operations (TTM)	793.25 Cr
Cash Flow from Financing (TTM)	379.29 Cr
Cash & Equivalents	880.24 Cr
Free Cash Flow (TTM)	235.04 Cr
Free Cash Flow/Share (TTM)	9.49

Balance Sheet
Total Assets	7.72 kCr
Total Liabilities	2.63 kCr
Shareholder Equity	5.08 kCr
Current Assets	3.77 kCr
Current Liabilities	2.09 kCr
Net PPE	3.05 kCr
Inventory	1.67 kCr
Goodwill	11.65 Cr

Capital Structure & Leverage
Debt Ratio	0.17
Debt/Equity	0.26
Interest Coverage	6.89
Interest/Cashflow Ops	8.1

Dividend & Shareholder Returns
Dividend/Share (TTM)	1.75
Dividend Yield	0.20%
Shares Dilution (1Y)	2.1%
Shares Dilution (3Y)	2.4%

Technical Indicators
RSI (14d)	49.35
RSI (5d)	75.33
RSI (21d)	48.18
MACD Signal	Sell
Stochastic Oscillator Signal	Hold
SharesGuru Signal	Buy
RSI Signal	Hold
RSI5 Signal	Sell
RSI21 Signal	Hold
SMA 5 Signal	Buy
SMA 10 Signal	Buy
SMA 20 Signal	Buy
SMA 50 Signal	Buy
SMA 100 Signal	Buy

Shareholder Name	Holding %
KRISHNA PRASAD CHIGURUPATI	31%
CHIGURUPATI UMA DEVI	3.73%
SBI LIFE INSURANCE CO. LTD	2.84%
KOTAK MAHINDRA LIFE INSURANCE COMPANY LTD.	1.7%
SMALLCAP WORLD FUND, INC	1.59%
ADITYA BIRLA SUN LIFE TRUSTEE PRIVATE LIMITED A/C	1.43%
TYCHE INVESTMENTS PRIVATE LIMITED	1.43%
BASAVA SANKARA RAO KOLLI	1.17%
360 ONE PIPE FUND	1.1%
PRAGNYA CHIGURUPATI	0.74%
CHIGURUPATI PRIYANKA	0.73%
SANTHI SREE RAMANAVARAPU	0.34%
SUSEELA DEVI CHIGURUPATI	0.03%
NIKHILA REDDY YEDAGURI	0.01%
HARSHA CHIGURUPATI	0%
KALIDINDI ABINAV VARMA	0%
VENKATA MAHESH KRISHNA NARRA	0%

Ticker	Name	Mkt Cap	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
SUNPHARMA	Sun Pharmaceutical Industries	4.67 LCr	62.14 kCr	+3.00%	+21.70%	38.59	7.51	-	-
DIVISLAB	Divi's Lab	2.2 LCr	11.68 kCr	+22.50%	+35.00%	75.08	18.8	-	-
CIPLA	Cipla	1.18 LCr	29.16 kCr	+2.20%	-1.80%	35.07	4.06	-	-
DRREDDY	Dr. Reddy's Lab	97.82 kCr	34.65 kCr	-13.10%	-2.40%	30.29	2.82	-	-
AUROPHARMA	Aurobindo Pharma	95.4 kCr	35.62 kCr	+6.50%	+55.00%	25.91	2.68	-	-

Description	(%) Q/Q	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Revenue From Operations	19.7%	5,366	4,482	4,506	4,512	3,765	3,238
Revenue From Operations	-	-	-	-	-	-	-
Other Income	58.3%	20	13	4.4	14	18	27
Other Income	-	-	-	-	-	-	-
Total Income	19.8%	5,386	4,495	4,511	4,526	3,783	3,264
Total Income	-	-	-	-	-	-	-
Cost of Materials	21.8%	2,100	1,725	2,208	2,353	2,036	1,590
Cost of Materials	-	-	-	-	-	-	-
Employee Expense	34.6%	888	660	598	472	401	408
Employee Expense	-	-	-	-	-	-	-
Finance costs	10.8%	114	103	106	56	23	26
Finance costs	-	-	-	-	-	-	-
Depreciation and Amortization	31.1%	296	226	207	184	159	151
Depreciation and Amortization	-	-	-	-	-	-	-
Other expenses	23%	1,416	1,151	1,031	819	758	583
Other expenses	-	-	-	-	-	-	-
Total Expenses	18.8%	4,591	3,865	3,964	3,839	3,225	2,560
Total Expenses	-	-	-	-	-	-	-
Profit Before exceptional items and Tax	26.4%	795	629	547	687	558	704
Profit Before exceptional items and Tax	-	-	-	-	-	-	-
Exceptional items before tax	-136.7%	-10	31	0	0	0	0
Total profit before tax	19%	785	660	547	687	558	704
Total profit before tax	-	-	-	-	-	-	-
Current tax	7.1%	196	183	165	177	138	195
Current tax	-	-	-	-	-	-	-
Deferred tax	71.4%	-6.19	-24.15	-23.31	-6.6	7.04	-40.47
Deferred tax	-	-	-	-	-	-	-
Total tax	19.6%	190	159	142	171	145	155
Total tax	-	-	-	-	-	-	-
Total profit (loss) for period	18.6%	595	502	405	517	413	549
Total profit (loss) for period	-	-	-	-	-	-	-
Other comp. income net of taxes	446.2%	143	27	20	57	40	-26.16
Other comp. income net of taxes	-	-	-	-	-	-	-
Total Comprehensive Income	39.6%	738	529	426	574	453	523
Total Comprehensive Income	-	-	-	-	-	-	-
Earnings Per Share, Basic	19.2%	24.47	20.69	16.73	21.05	16.66	22.05
Earnings Per Share, Basic	-	-	-	-	-	-	-
Earnings Per Share, Diluted	19.2%	24.46	20.68	16.72	21	16.6	21.95
Earnings Per Share, Diluted	-	-	-	-	-	-	-

Description	(%) Q/Q	Jun-2026	Mar-2026	Dec-2025	Sep-2025	Jun-2025	Mar-2025
Revenue From Operations	0.4%	1,477	1,471	1,388	1,297	1,210	1,197
Other Income	-83.7%	2.27	8.77	-3.64	-1.15	16	1.92
Total Income	0%	1,479	1,479	1,384	1,296	1,226	1,199
Cost of Materials	-23%	496	644	529	498	429	435
Employee Expense	6.3%	255	240	226	219	203	169
Finance costs	-37.5%	21	33	29	29	24	24
Depreciation and Amortization	-2.5%	80	82	74	72	69	64
Other expenses	0.3%	375	374	352	355	336	338
Total Expenses	0.5%	1,239	1,233	1,182	1,120	1,056	1,033
Profit Before exceptional items and Tax	-2.4%	240	246	202	176	170	167
Exceptional items before tax	-106.7%	0	16	0	0	-25.91	31
Total profit before tax	-8.4%	240	262	202	176	145	198
Current tax	93.9%	65	34	73	51	38	62
Deferred tax	-119.8%	-4.14	27	-20.88	-5.58	-6.24	-16.26
Total tax	-1.7%	60	61	52	45	32	46
Total profit (loss) for period	-10.9%	180	202	150	131	113	152
Other comp. income net of taxes	-55.4%	30	66	19	39	19	11
Total Comprehensive Income	-21.7%	210	268	169	170	132	163
Earnings Per Share, Basic	-13.4%	7.26	8.23	6.19	5.38	4.64	6.27
Earnings Per Share, Diluted	-15.4%	7.12	8.23	6.19	5.38	4.64	6.27

Description	(%) Q/Q	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Revenue From Operations	14.7%	3,474	3,030	3,755	3,931	3,238	3,135
Other Income	22.5%	50	41	5.78	9.93	18	14
Total Income	14.8%	3,524	3,071	3,761	3,941	3,256	3,149
Cost of Materials	9.5%	1,505	1,374	1,927	2,100	1,864	1,502
Employee Expense	10.8%	423	382	381	330	283	318
Finance costs	-3.2%	61	63	72	39	16	24
Depreciation and Amortization	12.4%	164	146	144	146	126	118
Other expenses	10.2%	814	739	666	601	553	446
Total Expenses	11.3%	2,976	2,674	3,170	3,277	2,736	2,416
Profit Before exceptional items and Tax	38.5%	548	396	591	664	520	733
Exceptional items before tax	-143.9%	-12.16	31	0	0	0	0
Total profit before tax	25.6%	536	427	591	664	520	733
Current tax	22.9%	135	110	151	170	134	197
Deferred tax	66.2%	-0.01	-1.99	4.77	-5.05	-0.38	-16.97
Total tax	25.2%	135	108	155	165	133	180
Total profit (loss) for period	25.8%	401	319	436	499	387	553
Other comp. income net of taxes	-1289.6%	-35.64	4.08	8.43	-4.69	14	-5.51
Total Comprehensive Income	13%	365	323	444	494	400	547
Earnings Per Share, Basic	27.2%	16.48	13.17	18	20.32	15.6	22.18
Earnings Per Share, Diluted	27.1%	16.47	13.17	17.99	20.3	15.55	22.09

Description	(%) Q/Q	Jun-2026	Mar-2026	Dec-2025	Sep-2025	Jun-2025	Mar-2025
Revenue From Operations	-8.6%	802	877	895	892	810	768
Other Income	-18.8%	14	17	12	7.88	13	30
Total Income	-8.7%	816	894	907	900	823	799
Cost of Materials	-4.8%	377	396	388	351	370	342
Employee Expense	5.7%	113	107	105	104	106	97
Finance costs	-42.6%	9.61	16	15	17	14	13
Depreciation and Amortization	-11.6%	39	44	41	41	40	38
Other expenses	0%	203	203	204	203	204	211
Total Expenses	-5.5%	719	761	757	738	720	703
Profit Before exceptional items and Tax	-26.7%	97	132	150	162	104	96
Exceptional items before tax	-	0	0	0	0	-12.16	31
Total profit before tax	-26.7%	97	132	150	162	91	127
Current tax	-7.1%	27	29	40	43	23	39
Deferred tax	-177.4%	-1.74	4.54	-1.69	-1.82	-1.03	-6.18
Total tax	-25%	25	33	39	41	22	33
Total profit (loss) for period	-27.6%	72	99	112	121	69	94
Other comp. income net of taxes	193.9%	24	-23.5	-2.1	-9.21	-0.83	14
Total Comprehensive Income	28.4%	96	75	109	111	69	108
Earnings Per Share, Basic	-37.5%	2.9	4.04	4.6	4.97	2.86	3.88
Earnings Per Share, Diluted	-39.5%	2.84	4.04	4.6	4.97	2.86	3.88

Category	GRANULES	Pharmaceuticals
PE	32.29	39.15
PS	3.84	5.34
Growth	24.2 %	11.6 %

Description	(%) Q/Q	Mar-2026	Sep-2025	Mar-2025	Sep-2024	Mar-2024	Sep-2023
Cash and cash equivalents	44.6%	880	609	466	209	381	296
Loans, current	-	0	0	0	0	0	0
Total current financial assets	34.4%	1,863	1,386	1,540	945	1,375	1,330
Inventories	12.4%	1,673	1,488	1,343	1,395	1,301	1,280
Total current assets	22.1%	3,768	3,087	3,115	2,605	2,905	2,792
Property, plant and equipment	16.8%	3,051	2,612	2,217	1,893	1,856	1,787
Capital work-in-progress	-42.2%	406	702	437	411	260	219
Goodwill	0%	12	12	0	0	0	0
Non-current investments	0%	0.84	0.84	22	22	22	21
Loans, non-current	-	0	0	0	0	0	0
Total non-current financial assets	4.8%	23	22	43	40	38	38
Total non-current assets	2.5%	3,952	3,857	3,137	2,827	2,616	2,473
Total assets	11.2%	7,720	6,944	6,253	5,433	5,521	5,265
Borrowings, non-current	-6.6%	297	318	312	157	69	98
Total non-current financial liabilities	-4%	458	477	471	236	152	184
Provisions, non-current	-9.6%	48	53	32	44	38	33
Total non-current liabilities	-0.2%	543	544	534	314	213	228
Borrowings, current	-21.2%	1,041	1,320	974	853	1,154	1,187
Total current financial liabilities	-13.8%	1,993	2,311	1,726	1,648	2,039	2,031
Provisions, current	50%	55	37	32	12	12	11
Current tax liabilities	-90.6%	3.25	25	18	19	5.61	10
Total current liabilities	-13.5%	2,092	2,417	2,003	1,692	2,082	2,069
Total liabilities	-11%	2,635	2,961	2,537	2,005	2,295	2,297
Equity share capital	4.3%	25	24	24	24	24	24
Non controlling interest	-	-	0	0	0	0	-
Total equity	27.7%	5,085	3,983	3,716	3,427	3,226	2,967
Total equity and liabilities	11.2%	7,720	6,944	6,253	5,433	5,521	5,265

Description	(%) Q/Q	Mar-2026	Sep-2025	Mar-2025	Sep-2024	Mar-2024	Sep-2023
Cash and cash equivalents	-82.7%	210	1,208	152	81	223	237
Loans, current	-114.8%	0	7.75	0	0	2.73	0
Total current financial assets	4.5%	1,530	1,464	1,469	1,263	1,866	1,765
Inventories	-0.5%	626	629	648	737	579	649
Total current assets	1.6%	2,296	2,259	2,287	2,214	2,634	2,576
Property, plant and equipment	2.9%	1,426	1,386	1,360	1,268	1,266	1,231
Capital work-in-progress	-1.7%	117	119	120	84	53	87
Non-current investments	31.2%	2,030	1,547	1,282	987	941	818
Loans, non-current	-	0	0	0	0	0	6.04
Total non-current financial assets	31%	2,047	1,563	1,299	1,003	957	840
Total non-current assets	15.8%	3,686	3,184	2,865	2,444	2,372	2,277
Total assets	9.9%	5,981	5,443	5,152	4,658	5,006	4,853
Borrowings, non-current	-	0	0	0	0	50	98
Total non-current financial liabilities	1.2%	88	87	86	5.23	57	106
Provisions, non-current	-26.7%	23	31	32	44	38	33
Total non-current liabilities	-9.9%	129	143	148	83	126	170
Borrowings, current	-20.4%	734	922	808	727	1,004	1,054
Total current financial liabilities	-17.3%	1,390	1,681	1,545	1,335	1,728	1,780
Provisions, current	37.1%	49	36	31	12	12	11
Current tax liabilities	-90.2%	3.25	24	12	6.01	4.22	9.01
Total current liabilities	-17.1%	1,453	1,752	1,600	1,363	1,769	1,814
Total liabilities	-16.5%	1,582	1,894	1,749	1,447	1,895	1,984
Equity share capital	4.3%	25	24	24	24	24	24
Total equity	24%	4,399	3,549	3,403	3,211	3,111	2,869
Total equity and liabilities	9.9%	5,981	5,443	5,152	4,658	5,006	4,853

Description	(%) Q/Q	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Finance costs	10.8%	114	103	106	56	23	-
Change in inventories	-550.7%	-139.35	-20.57	-140.73	-135.47	-184.03	-
Depreciation	31.1%	296	226	207	184	159	-
Impairment loss / reversal	-	4.9	0	0	0	0	-
Unrealised forex losses/gains	-462%	-11.67	4.5	-7.74	-9.15	-11.97	-
Adjustments for interest income	120.4%	7.04	3.74	2.8	4.51	13	-
Share-based payments	-	0	0	0.28	1.29	1.62	-
Net Cashflows from Operations	2.3%	1,033	1,010	630	915	477	-
Income taxes paid (refund)	67.1%	240	144	190	176	145	-
Net Cashflows From Operating Activities	-8.5%	793	867	439	739	332	-
Cashflows used in obtaining control of subsidiaries	-	198	0	0	0	0	-
Proceeds from sales of PPE	-	3.52	0	1.75	0.21	0.98	-
Purchase of property, plant and equipment	-2.5%	558	572	381	411	398	-
Proceeds from sales of investment property	-242.9%	0	1.7	0	0	0	-
Interest received	75.4%	5.56	3.6	2.77	5.05	12	-
Other inflows (outflows) of cash	53.6%	-57.46	-124.89	16	214	4.48	-
Net Cashflows From Investing Activities	-11.8%	-773.21	-691.29	-360.16	-191.36	-380.11	-
Proceeds from issuing shares	7425%	302	5	3.16	2.78	3.71	-
Proceeds from issuing other equity instruments	-	366	0	0	0	0	-
Payments to acquire or redeem entity's shares	-	0	0	0	311	0	-
Proceeds from borrowings	-100%	0.65	2,401	1,970	46	349	-
Repayments of borrowings	-95.3%	111	2,341	1,816	93	95	-
Payments of lease liabilities	17.6%	21	18	11	13	5.4	-
Dividends paid	0%	36	36	36	19	37	-
Interest paid	16.7%	120	103	103	53	24	-
Other inflows (outflows) of cash	-	0	0	0	-0.5	0	-
Net Cashflows from Financing Activities	504.2%	379	-92.51	7.66	-440.29	190	-
Effect of exchange rate on cash eq.	787.1%	12	2.24	2.62	-0.25	0.94	-
Net change in cash and cash eq.	389.3%	412	85	90	107	143	-

GRANULES - Granules India Ltd. Share Price

GRANULES

Price to Sales Ratio

Revenue (Last 12 mths)

Net Income (Last 12 mths)

GRANULES

GRANULES - Granules India Ltd. Share Price

GRANULES

Valuation

Fundamentals

Profitability

Price to Sales Ratio

Revenue (Last 12 mths)

Net Income (Last 12 mths)

Growth & Returns

Cash Flow & Liquidity

Balance Sheet

Capital Structure & Leverage

Dividend & Shareholder Returns

GRANULES

Investor Care

Financial Health

Technical Indicators

Share Holdings

Holding Pattern

Share Holding Details

Overall Distribution

Ownership Distribution

What does Granules India Ltd. do?

Important Disclosure & Data Context

Valuation

Fundamentals

Profitability

Growth & Returns

Cash Flow & Liquidity

Balance Sheet

Capital Structure & Leverage

Dividend & Shareholder Returns

Investor Care

Financial Health

Technical Indicators

Share Holdings

Holding Pattern

Share Holding Details

Overall Distribution

Ownership Distribution

What does Granules India Ltd. do?

Important Disclosure & Data Context